Drugs moving into the clinic: 2
The second in a series of periodic roundups of drugs that have moved from preclinical research into clinical testing via the announcement of a Phase I trial or an application for a trial to industry regulators.
Archives for January 12, 2007
Scientists publish 'atlas' of how proteins flex
Researchers have published an 'atlas' showing how proteins can change shape and interact with other molecules, which could prove an invaluable tool to drug developers.
UK chimeric stem cell research in the balance
The UK's Human Fertilisation and Embryology Authority (HFEA) has called for a public consultation into the use of animal eggs to create cloned hybrid or chimeric human embryos for laboratory-based disease research.
Predicting Proteomics
A new computer model could improve quantitative proteomics and speed up lead optimisation by predicting how a protein will break down during analysis.
AstraZeneca and Bristol-Myers Squibb collaborate on diabetes candidates
In a deal worth up to $1.35bn (€1bn) AstraZeneca (AZ) have agreed to co-develop and commercialise two of Bristol-Myers Squibb's (BMS) late stage diabetes compounds.
PerkinElmer continues cellular growth
PerkinElmer (PE) has continued its growth in the advanced cellular sciences sector, with the completed acquisitions of Euroscreen Products and Evotec Technologies.